CoChat

Migration Studies and Endocrine Disrupting Activities: Chemical Safety of Cosmetic Plastic Packaging

Open access

The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.

Abstract

The endocrine activity and endocrine disruptor (ED) chemical profiles of eleven plastic packaging materials covering five major polymer types (3PET, 1HDPE, 4LDPE, 2 PP, and 1SAN) were investigated using in vitro cell-based reporter-gene assays and a non-targeted chemical analysis using gas chromatography coupled to mass spectrometry (GC-MS). To mimic cosmetic contact, six simulants (acidic, alkaline, neutral water, ethanol 30%, glycerin, and paraffin) were used in migration assays performed by filling the packaging with simulant. After 1 month at 50 °C, simulants were concentrated by Solid Phase Extraction (SPE) or Liquid-Liquid Extraction (LLE). The migration profiles of seven major endocrine disrupting chemicals detected from GC-MS in the different materials and simulants were compared with Estrogen Receptor (ER) and Androgen Receptor (AR) activities. With low extraction of ED chemicals in aqueous simulants, no endocrine activities were recorded in the leachates. Paraffin was shown to be the most extracting simulant of antiandrogenic chemicals, while glycerin has estrogenic activities. Overall, ED chemical migration in paraffin was correlated with hormonal activity. The NIAS 2,4-di-tert-butyl phenol and 7,9-di-tert-butyl1-oxaspiro (4,5) deca-6,9-diene-2,8-dione were two major ED chemicals present in all polymers (principally in PP and PE) and in the highest quantity in paraffin simulant. The use of glycerin and liquid paraffin as cosmetic product simulants was demonstrated to be relevant and complementary for the safety assessment of released compounds with endocrine activities in this integrated strategy combining bioassays and analytical chemistry approaches.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/polym15194009

Cites

53 of 53 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Extraction and sample preparation procedure for all simulants. CF = Concentration Factor.
Figure 1 Extraction and sample preparation procedure for all simulants. CF = Concentration Factor.CC BY · PubMed Central
Figure 2 ER agonism and antiER antagonism with packaging extracts (M1 to M11) from the ethanol 30% simulant (S4) in Hela-9903 transcriptional activation assays. Cell viability was evaluated by the RealTime-Glo MT assay. The data represent the mean ± standard deviation of six data points (two experiments each in triplicate). Dotted lines highlight 10% 1 nM E2 normalized relative transcriptional activity (RTA) in the agonist mode or 70% 0.025 nM E2 normalized RTA in the antagonist mode as a threshold for categorizing positive data. E2—17β-estradiol; ER—estrogen receptor; CF—concentration factor.
Figure 2 ER agonism and antiER antagonism with packaging extracts (M1 to M11) from the ethanol 30% simulant (S4) in Hela-9903 transcriptional activation assays. Cell viability was evaluated by the RealTime-Glo MT assay. The data represent the mean ± standard deviation of six data points (two experiments each in triplicate). Dotted lines highlight 10% 1 nM E2 normalized relative transcriptional activity (RTA) in the agonist mode or 70% 0.025 nM E2 normalized RTA in the antagonist mode as a threshold for categorizing positive data. E2—17β-estradiol; ER—estrogen receptor; CF—concentration factor.CC BY · PubMed Central
Figure 3 ER agonism and antiER antagonism with packaging extracts (M1 to M11) from the paraffin simulant (S5) in Hela-9903 transcriptional activation assays. Cell viability was evaluated by the RealTime-Glo MT assay. The data represent the mean ± standard deviation of six data points (two experiments each in triplicate). Dotted lines highlight 10% 1 nM E2 normalized relative transcriptional activity (RTA) in the agonist mode or 70% 0.025 nM E2 normalized RTA in the antagonist mode as a threshold for categorizing positive data. E2—17β-estradiol; ER—estrogen receptor; CF—concentration factor.
Figure 3 ER agonism and antiER antagonism with packaging extracts (M1 to M11) from the paraffin simulant (S5) in Hela-9903 transcriptional activation assays. Cell viability was evaluated by the RealTime-Glo MT assay. The data represent the mean ± standard deviation of six data points (two experiments each in triplicate). Dotted lines highlight 10% 1 nM E2 normalized relative transcriptional activity (RTA) in the agonist mode or 70% 0.025 nM E2 normalized RTA in the antagonist mode as a threshold for categorizing positive data. E2—17β-estradiol; ER—estrogen receptor; CF—concentration factor.CC BY · PubMed Central
Figure 4 ER agonism and antiER antagonism with packaging extracts (M1 to M11) from the glycerin simulant (S6) in Hela-9903 transcriptional activation assays. Cell viability was evaluated by the RealTime-Glo MT assay. The data represent the mean ± standard deviation of six data points (two experiments each in triplicate). Dotted lines highlight 10% 1 nM E2 normalized relative transcriptional activity (RTA) in the agonist mode or 70% 0.025 nM E2 normalized RTA in the antagonist mode as a threshold for categorizing positive data. E2—17β-estradiol; ER—estrogen receptor; CF—concentration factor.
Figure 4 ER agonism and antiER antagonism with packaging extracts (M1 to M11) from the glycerin simulant (S6) in Hela-9903 transcriptional activation assays. Cell viability was evaluated by the RealTime-Glo MT assay. The data represent the mean ± standard deviation of six data points (two experiments each in triplicate). Dotted lines highlight 10% 1 nM E2 normalized relative transcriptional activity (RTA) in the agonist mode or 70% 0.025 nM E2 normalized RTA in the antagonist mode as a threshold for categorizing positive data. E2—17β-estradiol; ER—estrogen receptor; CF—concentration factor.CC BY · PubMed Central
Figure 5 AR agonism and antiAR antagonism with packaging extracts (M1 to M11) from the ethanol 30% simulant (S4) in MDA-kb2 transcriptional activation assays. Cell viability was evaluated by the RealTime-Glo MT assay. The data represent the mean ± standard deviation of six data points (two experiments each in triplicate). Dotted lines highlight 10% 1 nM DHT normalized relative transcriptional activity (RTA) in the agonist mode or 70% 0.25 nM DHT normalized RTA in the antagonist mode as a threshold for categorizing positive data. DHT—5α-dihydrotestosterone; AR—androgen receptor; CF—concentration factor.
Figure 5 AR agonism and antiAR antagonism with packaging extracts (M1 to M11) from the ethanol 30% simulant (S4) in MDA-kb2 transcriptional activation assays. Cell viability was evaluated by the RealTime-Glo MT assay. The data represent the mean ± standard deviation of six data points (two experiments each in triplicate). Dotted lines highlight 10% 1 nM DHT normalized relative transcriptional activity (RTA) in the agonist mode or 70% 0.25 nM DHT normalized RTA in the antagonist mode as a threshold for categorizing positive data. DHT—5α-dihydrotestosterone; AR—androgen receptor; CF—concentration factor.CC BY · PubMed Central
Figure 6 AR agonism and antiAR antagonism with packaging extracts (M1 to M11) from the paraffin simulant (S5) in MDA-kb2 transcriptional activation assays. Cell viability was evaluated by the RealTime-Glo MT assay. The data represent the mean ± standard deviation of six data points (two experiments each in triplicate). Dotted lines highlight 10% 1 nM DHT normalized relative transcriptional activity (RTA) in the agonist mode or 70% 0.25 nM DHT normalized RTA in the antagonist mode as a threshold for categorizing positive data. DHT—5α-dihydrotestosterone; AR—androgen receptor; CF—concentration factor.
Figure 6 AR agonism and antiAR antagonism with packaging extracts (M1 to M11) from the paraffin simulant (S5) in MDA-kb2 transcriptional activation assays. Cell viability was evaluated by the RealTime-Glo MT assay. The data represent the mean ± standard deviation of six data points (two experiments each in triplicate). Dotted lines highlight 10% 1 nM DHT normalized relative transcriptional activity (RTA) in the agonist mode or 70% 0.25 nM DHT normalized RTA in the antagonist mode as a threshold for categorizing positive data. DHT—5α-dihydrotestosterone; AR—androgen receptor; CF—concentration factor.CC BY · PubMed Central
Figure 7 AR agonism and antiAR antagonism with packaging extracts (M1 to M11) from the glycerin simulant (S6) in MDA-kb2 transcriptional activation assays. Cell viability was evaluated by the RealTime-Glo MT assay. The data represent the mean ± standard deviation of six data points (two experiments each in triplicate). Dotted lines highlight 10% 1 nM DHT normalized relative transcriptional activity (RTA) in the agonist mode or 70% 0.25 nM DHT normalized RTA in the antagonist mode as a threshold for categorizing positive data. DHT—5α-dihydrotestosterone; AR—androgen receptor; CF—concentration factor.
Figure 7 AR agonism and antiAR antagonism with packaging extracts (M1 to M11) from the glycerin simulant (S6) in MDA-kb2 transcriptional activation assays. Cell viability was evaluated by the RealTime-Glo MT assay. The data represent the mean ± standard deviation of six data points (two experiments each in triplicate). Dotted lines highlight 10% 1 nM DHT normalized relative transcriptional activity (RTA) in the agonist mode or 70% 0.25 nM DHT normalized RTA in the antagonist mode as a threshold for categorizing positive data. DHT—5α-dihydrotestosterone; AR—androgen receptor; CF—concentration factor.CC BY · PubMed Central
Figure 8 Chromatograms of M7 (HDPE) for all simulants. The blanks are simulants without contact with the material. C1 = 2,4-DTBP, C2 = 7,9-DTBO, C3 = DEP, C4 = BP, C6 = 2-EH, and C7 = 3,5-DTBH. “E” stands for the power of 10.
Figure 8 Chromatograms of M7 (HDPE) for all simulants. The blanks are simulants without contact with the material. C1 = 2,4-DTBP, C2 = 7,9-DTBO, C3 = DEP, C4 = BP, C6 = 2-EH, and C7 = 3,5-DTBH. “E” stands for the power of 10.CC BY · PubMed Central
Figure 9 Chromatograms of simulant 5 (paraffin) in contact with M2 (PET), M5 (PP), and M6 (SAN). C1 = 2,4-DTBP, C2 = 7,9-di-tert-butyl1-oxaspiro(4,5)deca-6,9-diene-2,8-dione, C3 = DEP, and C5 = Caprolactam. “E” stands for the power of 10.
Figure 9 Chromatograms of simulant 5 (paraffin) in contact with M2 (PET), M5 (PP), and M6 (SAN). C1 = 2,4-DTBP, C2 = 7,9-di-tert-butyl1-oxaspiro(4,5)deca-6,9-diene-2,8-dione, C3 = DEP, and C5 = Caprolactam. “E” stands for the power of 10.CC BY · PubMed Central
Figure 10 ED chemical profiles for each simulant with all materials (A) or for each material with all simulants (B). C1 = 2,4-DTBP, C2 = 7,9-DTBO, C3 = DEP, C4 = BP, C5 = Caprolactam, C6 = 2-EH, and C7 = 3,5-DTBH. M1, M2, M3: PET, M4, M5: PP, M6: SAN, M7: HDPE, M8: LDPE, M9, M10: coex LDPE, M11: HDPE/LDPE. S1, S2, S3: water; S4: ethanol 30%; S5: paraffin; S6: glycerin; M: material; S: simulant. Values have been normalized by the sum of the areas for each component, expressed as a percentage.
Figure 10 ED chemical profiles for each simulant with all materials (A) or for each material with all simulants (B). C1 = 2,4-DTBP, C2 = 7,9-DTBO, C3 = DEP, C4 = BP, C5 = Caprolactam, C6 = 2-EH, and C7 = 3,5-DTBH. M1, M2, M3: PET, M4, M5: PP, M6: SAN, M7: HDPE, M8: LDPE, M9, M10: coex LDPE, M11: HDPE/LDPE. S1, S2, S3: water; S4: ethanol 30%; S5: paraffin; S6: glycerin; M: material; S: simulant. Values have been normalized by the sum of the areas for each component, expressed as a percentage.CC BY · PubMed Central
Figure 11 Score plots in the PC1–PC2 plan are grouped by material families on the left and by simulant families on the right.
Figure 11 Score plots in the PC1–PC2 plan are grouped by material families on the left and by simulant families on the right.CC BY · PubMed Central
Figure 12 Scores plot in PC1–PC2 plan grouped by antiAR on the left and by ER activity families on the right.
Figure 12 Scores plot in PC1–PC2 plan grouped by antiAR on the left and by ER activity families on the right.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 3

  1. Test No. 458: Stably Transfected Human Androgen Receptor Transcriptional Activation Assay for Detection of Androgenic Agonist and Antagonist Activity of Chemicals Available online: https://www.oecd-ilibrary.org/environment/test-no-458-stably-transfected-human-androgen-receptor-transcriptional-activation-assay-for-detection-of-androgenic-agonist-and-antagonist-activity-of-chemicals_9789264264366-en (accessed on 30 June 2021)
  2. Yang Y.-P. Hu C.-Y. Zhong H. Wang Z.-Y. Zeng G.-F. Degradation of Irgafos 168 and Determination of Its Degradation Products Mod. Food Sci. Technol. 2016 32 304 309 10.13982/j.mfst.1673-9078.2016.6.046 · doi:10.13982/j.mfst.1673-9078.2016.6.046
  3. Sheftel V.O. Indirect Food Additives and Polymers: Migration and Toxicology CRC Press Boca Raton, FL, USA 2014 978-0-429-07675-6

Cited by

See all 6

Metadata

Authors
Bou-Maroun, E., Dahbi, L., Dujourdy, L., Ferret, P.-J., & Chagnon, M.-C.
Affiliations
  • PAM UMR A 02.102, Food and Microbiological Processes, Institut Agro, Université Bourgogne Franche-Comté, 1 Esplanade Erasme, F-21000 Dijon, France
  • Inserm (FR)
  • Institut Agro Dijon (FR)
  • Pierre Fabre (France) (FR)
Venue
Polymers
Publisher
MDPI AG
Published
2023-10-06
Volume
15
Issue
19
Pages
4009
ISSN
2073-4360 (ISSN-L)
OpenAlex
W4387435165
Cited by
5
References
51
Citations by year
2026: 2 · 2025: 1 · 2024: 2
FWCI
0.57
Type
journal article
Language
en
Open access
Locations
  • Polymers (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • HAL (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Topics
  • Physical Sciences › Environmental Science › Health, Toxicology and Mutagenesis › Effects and risks of endocrine disrupting chemicals
  • Physical Sciences › Materials Science › Polymers and Plastics › Polymer Science and PVC
  • Physical Sciences › Chemistry › Analytical Chemistry › Analytical chemistry methods development
Keywords
endocrine disruptors, chemical migration, cosmetic packaging, plastic packaging, estrogenic activity, androgenic activity, estrogen receptor, androgen receptor, 2,4-di-tert-butylphenol, glycerol, alkanes, polyethylene, polypropylene, safety assessment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.